Dental PlaquePhase 2MGPNCT01142843
Preliminary Evidence of the Efficacy of a Mouthwash Containing 5% Propolis for the Control of Plaque and Gingivitis
A Phase 2 study testing green propolis mouthwash in people with Dental Plaque and Gingivitis, run by Federal University of Minas Gerais at 1 site in Brazil.
Trial summary
Mouthwash based on medicinal plants and propolis can be easily found in the Brazilian market even if it has not been tested in reliable clinical trials on its efficacy or possible unpleasant side effects like the ones which alter the hard and soft oral tissues. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Dental Plaque, Gingivitis
- What is being tested?
- green propolis mouthwash
- How many people
- 25 participants
- Where
- 1 siteBrazil
- Study dates
- Aug 2009to Mar 2010
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- age 18-60 years
- generally good health
- not pregnant nor breastfeeding
- a minimum of 20 sound, natural teeth
- a mean plaque index (PI) (Turesky modification of the Quigley-Hein Plaque Index, 1970) of at least 1.5 or more
- a mean gingival index (GI) (Talbott modification Gingival Index of the Löe-Silness, 1977) of at least 1.0 or more
- signing the terms of agreement
Who cannot join
- Subjects with orthodontic appliances or removable prosthetics
- Subjects with tumors of the soft or hard oral tissues
- Subjects with advanced periodontal disease
- Subjects that received antibiotic therapy 2 weeks before the start of the study
- Subjects with hipersensibility to propolis confirmed
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Universidade Federal de Minas Gerais (UFMG)
Belo Horizonte, Minas Gerais, 31270-901
About this study
Official title: Clinical Preliminary Evidence of the Efficacy of a Mouthwash Containing 5% Propolis for the Control of Plaque and Gingivitis: Phase II Study
Mouthwash based on medicinal plants and propolis can be easily found in the Brazilian market even if it has not been tested in reliable clinical trials on its efficacy or possible unpleasant side effects like the ones which alter the hard and soft oral tissues. The aim of this study was to obtain preliminary evidence of efficacy of an alcohol-free mouthwash containing 5% green propolis (MGP 5%) on the control of plaque and gingivitis. Were chosen twenty-five subjects that are UFMG employees and individuals who would begin treatment on an extension project called Supportive Periodontal Therapy at the Faculty of Dentistry of Federal University of Minas Gerais, Belo Horizonte, from August to December 2009. The subjects went through a dental prophylaxis before starting rinse. They were then instructed to rinse twice a day for a minute, immediately after brushing (morning and night), using the 10 ml of the MGP 5%. After 45 and 90 days using the product the individuals returned for a clinical evaluation which considered changes in the soft and hard oral tissues and involved collecting plaque and gingivitis indexes. On their last appointment the subjects answered a questionnaire about their level of appreciation and acceptability of the mouthwash. Compliance with the treatment was also evaluated through an attendance form. For the statistic analysis we used BioEstat 4.0 and Excel 2007.
Read the detailed description
The first reference to mouthrinse as a formal practice is credited to Chinese medicine, about 2700 B.C.E., to treatment the diseases of the gums (Fischman, 1997).
The gram-positive and gram-negative bacteria that compose oral biofilms produces many metabolites that induce gingival inflammation (that is, gingivitis). Gingivitis can lead to periodontitis, a condition in which gingival and bone tissues are destroyed. The majority of the population may not perform mechanical plaque removal sufficiently. Thus, antimicrobial mouthrinses that improve daily home care may provide an effective way of removing or controlling bacterial plaque to limit gingivitis and periodontitis (Haffajee et al., 2008).
The main indications are either the improvement of dental health (plaque and gingivitis elimination in particular) or the prevention of infections caused by bacteria of the oral cavity in specific situations, such as tooth extraction, intraoral surgical procedures or immune suppression due to cancer therapy or transplantation. The use of antimicrobial mouthrinses has been proposed to reduce the levels of oral bacteria, specially Streptococcus mutans (Kocak et al., 2009).
In fact, it has been shown that chemotherapeutic mouthrinses are an effective adjunct to regular brushing and flossing for patients with gingivitis, providing a clinically significant benefit in the reduction of plaque and gingivitis (Haffajee et al., 2008).
Propolis is a resinous substance collected by honeybees from buds and exudates of certain trees and plants, and stored inside their hives. It has been used in folk medicine from ancient times to treat various ailments (Kunimasa et al., 2009).
The action against microorganisms is an essential characteristic of propolis, and humans have used it for centuries for its pharmaceutical properties (Kalogeropoulos et al., 2009).
The antibacterial activity of propolis is reported due to flavonoids, aromatic acids and esters present in resins. Galangin, pinocebrin and pinostrobin are known as the flavonoids agents more effective against bacteria. Ferulic acid and caffeic acid also contribute to the bactericidal action of propolis (Marcucci, 1995). Thus, the purpose of this study was to show a preliminary evidence about the effect of an alcohol-free mouthwash containing 5% of green propolis for the control of plaque and gingivitis in subjects for three months.
Materials and Methods
Design study and Product tested
This was an interventional study of phase II for three months, follow up type, and was conducted at the Faculty of Dentistry of Federal University of Minas Gerais, Brazil, from August 2009 to April 2010.
The alcohol-free mouthwash containing 5% green propolis (MGP 5%) used in that study was handled according to our request by PharmaNéctar ® (Belo Horizonte), within the standards required by ANVISA (Brazil, 2000) and within the requirements of ISO 9001 and GMP International (Table 1).
Participants
Twenty five subjects, age varying from 18 to 60 years (median age 35,92 ±9,7), with generally good health, not pregnant nor breastfeeding, who met the following inclusion criteria, were included into the study: a minimum of 20 sound, natural teeth; a mean plaque index (PI) (Turesky modification of the Quigley-Hein Plaque Index, 1970) of at least 1.5; a mean gingival index (GI) (Talbott modification Gingival Index of the Löe-Silness, 1977) of at least 1.0. Subjects with orthodontic appliances or removable prosthetics, tumors of the soft or hard oral tissues, advanced periodontal disease, or that received antibiotic therapy 2 weeks before the start of the study or that presented hipersensibility to propolis were excluded. Third molars and those teeth with cervical restorations or prosthetic crowns were not included in the tooth count. The selection of participants was made by convenience, based especially on the availability for the study, along the study was conducted. All subjects read and signed informed consent forms before the start of the study. The protocol for the study was approved by the local ethical review committee (Committee of Bioethics in Research at the Federal University of Minas Gerais (COEP/UFMG - 0600/09).
Assessing mouthwash
The examination baseline consisted of a complete soft and hard tissues examination that was performed to register the condition of oral mucosa, so that any changes in the course of the study could be identified , making assessment to whether these changes could be related to the mouthrinse. The gingivitis of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all elegible teeth was scored using the Talbott modification Gingival Index of the Löe-Silness - GI, 1977, in which the gum was scored on a four-point scale from 0 (absence of inflammation) to 3 ( severe inflammation). The supragingival plaque of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all elegible teeth was scored using the Turesky modification of the Quigley-Hein Plaque Index - PI, 1970. Previously, disclosing with erythrosine 3% solution, plaque was scored on a six point scale from 0 (no plaque) to 5 (plaque covers two-thirds or more of the tooth surface). Of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all scorable teeth was scored using the Turesky modification of the Quigley-Hein Plaque Index - PI, 1970. There were also evaluated Severity Plaque Index and Severity Gingival Index (Palomo et al., 1989; Volpe et al.,1993). These index measured the rate of the surface that had high count of plaque (count similar to 3, 4, 5 of the modification Quigley-Hein Plaque Index, 1970) and high gingival index (count similar to 2,3 modification Gingival Index of the Löe-Silness, 1977.
These examinations were all repeated after 45 and 90 days of use of mouthrinse. After baseline examination, each subject received a complete oral prophylaxis, which included the removal of all supragingival plaque and calculus deposits. Soon after, the subjects received the 5% green propolis-containing mouthrinse alcohol-free (MGP 5%) and a toothbrush. They were instructed to brush their teeth as usual and to rinse with the 10mL of MGP 5%, twice a day, for one minute, right after their meals in the morning and at night. Participants were required not to use another mouthrinse throughout the study. When new supplies were issued, subjects returned their used materials, so that compliance to theproduct could be monitored.
Reproducibility of clinical examinations
All examinations were conducted by a single examiner trained to optimize the consistency of the study. Prior to the study, the adviser trained the dental examiner, as a "gold standard", directing him to introduce the periodontal probe, gently, into the gingival sulcus,, keeping the instrument parallel to the long axis of the tooth, sliding it from the distal to the mesial so delicately in the buccal and lingual surface of each evaluated tooth. For calibration, there was examined nine subjects not included in the study.
For the plaque index it was performed a theoretical calibration. Soon after, photos were used to obtain a standardization intra-examiner. The photos were exhibited by the adviser to the examiner that noted the values of plaque index corresponding to each picture. After 15 days, the same pictures were exposed to the examiner that noted again the values of plaque index. Next, the plaque index obtained in the first and second time was compared to verify the level of intra-examiner. Then, we obtained a kappa value of 0.73, considered a substantial estimate of reliability (Landis \& Koch, 1977).
Statistical Analysis
The statistical package BioEstat version 4.0 was used for data analysis in this study. The average adjusted in the baseline for both scores of the modified Plaque Index of Quigley-Hein (1970) and modified Gingival Index of Löe-Silness (1977) as for the corresponding severity scores, for being a non-parametric distribution, were compared through covariance analysis, by Friedman test for data obtained at 45 and 90 days of the study. All statistical tests of hypotheses had two strands and was considered a significance level of p< 0.05 (Allen et al. 1998; Arweiler et al., 2001).
- Conditions
- Dental Plaque, Gingivitis
- Being tested
- green propolis mouthwash
- Keywords
- clinical trial, mouthwash, green propolis, dental plaque, gingivitis
- Medical subject headings
- Dental Plaque, Gingivitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
green propolis mouthwashDrug
Also called mouthrinse, Brazilian propolis, Baccharis dracunculifolia
The subjects were instructed to brush their teeth as usual and to rinse with the 10mL of Mouthwash contain 5% Green Propolis, twice a day, for one minute, right after their meals in the morning and at night. The treatment was performed during three months
What is being measured
The primary outcome is the main question the study is designed to answer.
Efficacy of a mouthwash containing 5% propolis for the control of gingivitis
Difference in the Gingival Index scores between the start and the end of the study.
Measured: 90 days
Secondary outcomes (1)
Efficacy of a mouthwash containing 5% propolis for the control of plaque
Difference in the Plaque Index scores between the start and the end of the study.
Measured: 90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jun 2010 (estimated)
- Study startAug 2009
- Primary completionOct 2009
- Study completionMar 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dental PlaqueStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 25 participants (actual)
Sponsor and investigators
- Lead sponsor
- Federal University of Minas Gerais
- Sponsor type
- University, hospital or other
- Collaborators
- Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do estado de Minas Gerais
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01142843
- Sponsor's protocol ID
- VSantos-UFMG
- Acronym
- MGP
- Status last verified
- May 2009
- First submitted
- 10 Jun 2010
- Last updated
- 2 Jul 2010
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 2 Jul 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Preliminary Evidence of the Efficacy of a Mouthwash Containing 5% Propolis for the Control of Plaque and Gingivitis: Phase II Study
- ClinicalTrials.gov ID
- NCT01142843
- Acronym / sponsor ID
- MGP / VSantos-UFMG
- Conditions
- Dental Plaque, Gingivitis
- Keywords
- clinical trial, mouthwash, green propolis, dental plaque, gingivitis
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 25 participants (actual)
- Lead sponsor
- Federal University of Minas GeraisUniversity, hospital or other
- Collaborators
- Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do estado de Minas Gerais
- Study start
- Aug 2009
- Primary completion
- Oct 2009 (actual)
- Study completion
- Mar 2010 (actual)
- First posted
- 11 Jun 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Mouthwash based on medicinal plants and propolis can be easily found in the Brazilian market even if it has not been tested in reliable clinical trials on its efficacy or possible unpleasant side effects like the ones which alter the hard and soft oral tissues. The aim of this study was to obtain preliminary evidence of efficacy of an alcohol-free mouthwash containing 5% green propolis (MGP 5%) on the control of plaque and gingivitis. Were chosen twenty-five subjects that are UFMG employees and individuals who would begin treatment on an extension project called Supportive Periodontal Therapy at the Faculty of Dentistry of Federal University of Minas Gerais, Belo Horizonte, from August to December 2009. The subjects went through a dental prophylaxis before starting rinse. They were then instructed to rinse twice a day for a minute, immediately after brushing (morning and night), using the 10 ml of the MGP 5%. After 45 and 90 days using the product the individuals returned for a clinical evaluation which considered changes in the soft and hard oral tissues and involved collecting plaque and gingivitis indexes. On their last appointment the subjects answered a questionnaire about their level of appreciation and acceptability of the mouthwash. Compliance with the treatment was also evaluated through an attendance form. For the statistic analysis we used BioEstat 4.0 and Excel 2007.
Detailed description
The first reference to mouthrinse as a formal practice is credited to Chinese medicine, about 2700 B.C.E., to treatment the diseases of the gums (Fischman, 1997).
The gram-positive and gram-negative bacteria that compose oral biofilms produces many metabolites that induce gingival inflammation (that is, gingivitis). Gingivitis can lead to periodontitis, a condition in which gingival and bone tissues are destroyed. The majority of the population may not perform mechanical plaque removal sufficiently. Thus, antimicrobial mouthrinses that improve daily home care may provide an effective way of removing or controlling bacterial plaque to limit gingivitis and periodontitis (Haffajee et al., 2008).
The main indications are either the improvement of dental health (plaque and gingivitis elimination in particular) or the prevention of infections caused by bacteria of the oral cavity in specific situations, such as tooth extraction, intraoral surgical procedures or immune suppression due to cancer therapy or transplantation. The use of antimicrobial mouthrinses has been proposed to reduce the levels of oral bacteria, specially Streptococcus mutans (Kocak et al., 2009).
In fact, it has been shown that chemotherapeutic mouthrinses are an effective adjunct to regular brushing and flossing for patients with gingivitis, providing a clinically significant benefit in the reduction of plaque and gingivitis (Haffajee et al., 2008).
Propolis is a resinous substance collected by honeybees from buds and exudates of certain trees and plants, and stored inside their hives. It has been used in folk medicine from ancient times to treat various ailments (Kunimasa et al., 2009).
The action against microorganisms is an essential characteristic of propolis, and humans have used it for centuries for its pharmaceutical properties (Kalogeropoulos et al., 2009).
The antibacterial activity of propolis is reported due to flavonoids, aromatic acids and esters present in resins. Galangin, pinocebrin and pinostrobin are known as the flavonoids agents more effective against bacteria. Ferulic acid and caffeic acid also contribute to the bactericidal action of propolis (Marcucci, 1995). Thus, the purpose of this study was to show a preliminary evidence about the effect of an alcohol-free mouthwash containing 5% of green propolis for the control of plaque and gingivitis in subjects for three months.
Materials and Methods
Design study and Product tested
This was an interventional study of phase II for three months, follow up type, and was conducted at the Faculty of Dentistry of Federal University of Minas Gerais, Brazil, from August 2009 to April 2010.
The alcohol-free mouthwash containing 5% green propolis (MGP 5%) used in that study was handled according to our request by PharmaNéctar ® (Belo Horizonte), within the standards required by ANVISA (Brazil, 2000) and within the requirements of ISO 9001 and GMP International (Table 1).
Participants
Twenty five subjects, age varying from 18 to 60 years (median age 35,92 ±9,7), with generally good health, not pregnant nor breastfeeding, who met the following inclusion criteria, were included into the study: a minimum of 20 sound, natural teeth; a mean plaque index (PI) (Turesky modification of the Quigley-Hein Plaque Index, 1970) of at least 1.5; a mean gingival index (GI) (Talbott modification Gingival Index of the Löe-Silness, 1977) of at least 1.0. Subjects with orthodontic appliances or removable prosthetics, tumors of the soft or hard oral tissues, advanced periodontal disease, or that received antibiotic therapy 2 weeks before the start of the study or that presented hipersensibility to propolis were excluded. Third molars and those teeth with cervical restorations or prosthetic crowns were not included in the tooth count. The selection of participants was made by convenience, based especially on the availability for the study, along the study was conducted. All subjects read and signed informed consent forms before the start of the study. The protocol for the study was approved by the local ethical review committee (Committee of Bioethics in Research at the Federal University of Minas Gerais (COEP/UFMG - 0600/09).
Assessing mouthwash
The examination baseline consisted of a complete soft and hard tissues examination that was performed to register the condition of oral mucosa, so that any changes in the course of the study could be identified , making assessment to whether these changes could be related to the mouthrinse. The gingivitis of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all elegible teeth was scored using the Talbott modification Gingival Index of the Löe-Silness - GI, 1977, in which the gum was scored on a four-point scale from 0 (absence of inflammation) to 3 ( severe inflammation). The supragingival plaque of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all elegible teeth was scored using the Turesky modification of the Quigley-Hein Plaque Index - PI, 1970. Previously, disclosing with erythrosine 3% solution, plaque was scored on a six point scale from 0 (no plaque) to 5 (plaque covers two-thirds or more of the tooth surface). Of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all scorable teeth was scored using the Turesky modification of the Quigley-Hein Plaque Index - PI, 1970. There were also evaluated Severity Plaque Index and Severity Gingival Index (Palomo et al., 1989; Volpe et al.,1993). These index measured the rate of the surface that had high count of plaque (count similar to 3, 4, 5 of the modification Quigley-Hein Plaque Index, 1970) and high gingival index (count similar to 2,3 modification Gingival Index of the Löe-Silness, 1977.
These examinations were all repeated after 45 and 90 days of use of mouthrinse. After baseline examination, each subject received a complete oral prophylaxis, which included the removal of all supragingival plaque and calculus deposits. Soon after, the subjects received the 5% green propolis-containing mouthrinse alcohol-free (MGP 5%) and a toothbrush. They were instructed to brush their teeth as usual and to rinse with the 10mL of MGP 5%, twice a day, for one minute, right after their meals in the morning and at night. Participants were required not to use another mouthrinse throughout the study. When new supplies were issued, subjects returned their used materials, so that compliance to theproduct could be monitored.
Reproducibility of clinical examinations
All examinations were conducted by a single examiner trained to optimize the consistency of the study. Prior to the study, the adviser trained the dental examiner, as a "gold standard", directing him to introduce the periodontal probe, gently, into the gingival sulcus,, keeping the instrument parallel to the long axis of the tooth, sliding it from the distal to the mesial so delicately in the buccal and lingual surface of each evaluated tooth. For calibration, there was examined nine subjects not included in the study.
For the plaque index it was performed a theoretical calibration. Soon after, photos were used to obtain a standardization intra-examiner. The photos were exhibited by the adviser to the examiner that noted the values of plaque index corresponding to each picture. After 15 days, the same pictures were exposed to the examiner that noted again the values of plaque index. Next, the plaque index obtained in the first and second time was compared to verify the level of intra-examiner. Then, we obtained a kappa value of 0.73, considered a substantial estimate of reliability (Landis \& Koch, 1977).
Statistical Analysis
The statistical package BioEstat version 4.0 was used for data analysis in this study. The average adjusted in the baseline for both scores of the modified Plaque Index of Quigley-Hein (1970) and modified Gingival Index of Löe-Silness (1977) as for the corresponding severity scores, for being a non-parametric distribution, were compared through covariance analysis, by Friedman test for data obtained at 45 and 90 days of the study. All statistical tests of hypotheses had two strands and was considered a significance level of p< 0.05 (Allen et al. 1998; Arweiler et al., 2001).
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- age 18-60 years
- generally good health
- not pregnant nor breastfeeding
- a minimum of 20 sound, natural teeth
- a mean plaque index (PI) (Turesky modification of the Quigley-Hein Plaque Index, 1970) of at least 1.5 or more
Key exclusion criteria (5 listed)
- Subjects with orthodontic appliances or removable prosthetics
- Subjects with tumors of the soft or hard oral tissues
- Subjects with advanced periodontal disease
- Subjects that received antibiotic therapy 2 weeks before the start of the study
- Subjects with hipersensibility to propolis confirmed
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| green propolis mouthwashAlso: mouthrinse, Brazilian propolis, Baccharis dracunculifoliaThe subjects were instructed to brush their teeth as usual and to rinse with the 10mL of Mouthwash contain 5% Green Propolis, twice a day, for one minute, right after their meals in the morning and at night. The treatment was performed during three months | Drug | – |
Primary outcome
Efficacy of a mouthwash containing 5% propolis for the control of gingivitis
Time frame: 90 days
Difference in the Gingival Index scores between the start and the end of the study.
1 secondary outcome
Efficacy of a mouthwash containing 5% propolis for the control of plaque
Time frame: 90 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jul 2010.
Related trials for Dental Plaque
Active, not recruitingPhase 3
A Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis
Plaque, Gingivitis
Not yet recruiting
Effectiveness of Personalized Digital Oral Health Intervention in Patients With Fixed Orthodontic Appliances.
Oral Hygiene in Patients With Fixed Orthodontic Appliances, Dental Plaque
Not yet recruiting
Effect of Xylitol- Versus Erythritol-Sweetened Mints on Plaque ATP-Bioluminescence Readings
Dental Caries, Dental Plaque
Not yet recruitingObservational study
Plaque and Bleeding on Probing Around Implants Supporting Fixed Full-Arch Dental Prostheses
Peri-Implant Health
Not yet recruiting
Effectiveness of Oil Pulling Using Oils in Comparison With Mouthwash for Gingivitis
Gingivitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing green propolis mouthwash in people with Dental Plaque and Gingivitis, run by Federal University of Minas Gerais at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Efficacy of a mouthwash containing 5% propolis for the control of gingivitis (time frame: 90 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2010.